Charles Schwab Investment Management Inc Age X Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.56 - $2.7 $16,606 - $28,741	-10,645 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$0.68 - $1.13 $30,068 - $49,966	-44,218 Reduced 80.6%	10,645 $11,000
Q2 2019 Aug 09, 2019	BUY	$2.58 - $4.92 $63,971 - $121,991	24,795 Added 82.46%	54,863 $202,000
Q1 2019 May 14, 2019	BUY	$3.0 - $4.85 $31,935 - $51,628	10,645 Added 54.81%	30,068 $122,000
Q4 2018 Feb 14, 2019	BUY	$2.49 - $5.5 $48,363 - $106,826	19,423 New	19,423 $59,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.